Found this interesting article online not sure if it is old news at all?
Thalidomide alleviates LL37-induced rosacea-like skin inflammation.
Thalidomide reduces the production of chemokines and cytokines associated with rosacea.
Thalidomide represses LL37-induced Th1/Th17 immune responses in the skin.
Thalidomide decreases cutaneous angiogenesis in LL37-induced rosacea-like mice.
Thalidomide suppresses NF-κB activation in keratinocytes.
Thalidomide alleviates LL37-induced rosacea-like skin inflammation.
Thalidomide reduces the production of chemokines and cytokines associated with rosacea.
Thalidomide represses LL37-induced Th1/Th17 immune responses in the skin.
Thalidomide decreases cutaneous angiogenesis in LL37-induced rosacea-like mice.
Thalidomide suppresses NF-κB activation in keratinocytes.
Comment